SEB Asset Management AB »

Bridgebio Pharma shares owned by SEB Asset Management AB

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by SEB Asset Management AB from 13F filings

Historical chart of SEB Asset Management AB investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by SEB Asset Management AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by SEB Asset Management AB

Quarter filed Position value Share count Share price at filing
2026-03-31 $18M 236k 74.26

More positions owned by SEB Asset Management AB

NVIDIA Corporation (NVDA)
Apple (AAPL)
Astrazeneca Ord (AZN)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)
Mastercard Incorporated Cl A (MA)
Citigroup Com New (C)
Tesla Motors (TSLA)

View all positions for SEB Asset Management AB

Top funds holding Bridgebio Pharma

Vanguard Group
BlackRock
Kohlberg Kravis Roberts & Co
Henderson Group
Viking Global Investors
Farallon Capital Management
Vanguard Portfolio Management
Vanguard Capital Management
UBS Group
Aisling Capital Management
State Street Corporation
Jane Street
Geode Capital Management
Invesco
Susquehanna International

View all funds holding Bridgebio Pharma